Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists

Affiliations

• ¹ Department of Endocrinology & Nutrition, CIBERDEM - IR Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Faculty of Medicine, University of Vic & Central University of Catalonia, Vic, Spain. Electronic address: didacmauricio@gmail.com.
• ² Department of Endocrinology & Nutrition, Clínica Universidad de Navarra, Pamplona, Spain; Fundación de la Sociedad Española de Endocrinología y Nutrición, Madrid, Spain.
• ³ Department of Endocrinology & Nutrition, CIBERDEM - IR Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Sociedad Española de Diabetes, Madrid, Spain.
• ⁴ Digestive Diseases Department & CIBEREHD, Virgen del Rocío University Hospital, Institute of Biomedicine of Seville (HUVR/CSIC/US), University of Seville, Seville, Spain.
• ⁵ Division of Endocrinology, Diabetes & Metabolism, University of Florida, Gainesville, USA.
• ⁶ Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia, USA; The Global NASH Council, Washington, DC, USA.
• ⁷ The Global NASH Council, Washington, DC, USA; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA.